Following a public consultation, EFSA has finalised the strategy for its next re-evaluation of the toxicity of bisphenol A (BPA). The Authority has today published a “scientific protocol” that transparently details upfront the scope, methodology and information needs before the assessment starts.
BPA is a chemical widely used to manufacture plastics and resins. The Authority publicly consulted on a draft version of the protocol that sets out in advance the rules for the future re-evaluation of BPA and held a public meeting with specialists, interested members of the public and other stakeholders.
EFSA will set up a new working group in 2018 and start collecting scientific papers and data. This will include the report of the CLARITY-BPA two-year core study on rodents and publications of academic studies developed from the CLARITY study, when they become available.
The CLARITY-BPA project was developed in the USA by the National Institute of Environmental Health Sciences (NIEHS) and the Food and Drug Administration (FDA) and run by the National Toxicology Program (NTP).
EFSA will continue to liaise with the European Chemicals Agency and national scientific advisory bodies in EU Member States who are also working on BPA.